Proportion and reasons for loss to follow-up in a cohort study of people who inject drugs to measure HIV and HCV incidence in Kerman, Iran

BACKGROUND: Understanding the reasons for loss to follow-up (LTFU) in cohort studies, especially among marginalized groups such as people who inject drugs (PWID), is needed to strengthen the rigor of efficacy trials for prevention and treatment interventions. We assessed the proportion and reasons f...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Subst Abuse Treat Prev Policy
Главные авторы: Mousavian, Ghazal, Ghalekhani, Nima, Tavakoli, Fatemeh, McFarland, Willi, Shahesmaeili, Armita, Sharafi, Heidar, Khezri, Mehrdad, Mehmandoost, Soheil, Zarei, Jasem, Sharifi, Hamid, Mirzazadeh, Ali
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2021
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017615/
https://ncbi.nlm.nih.gov/pubmed/33794943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13011-021-00368-9
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы